Oral Presentations and Posters Based on Einstein Aging Study Investigate Risk Factors and Predictors of aMCI and Dementia in Older Adults
July 14, 2015—(BRONX, NY)—Investigators at Albert Einstein College of Medicine of Yeshiva University and Montefiore Health System will present multiple findings at the Alzheimer’s Association International Conference, taking place July 18-23 in Washington, D.C. Research topics include risk factors for developing amnestic mild cognitive impairment (aMCI)—a condition characterized by memory problems, and is most often a precursor of Alzheimer’s dementia. The researchers will also detail their work on new tests to predict the onset of dementia and potential new interventions to support cognitive function.
“Though incidence of Alzheimer’s disease and other causes of dementia are common, these brain disorders remain poorly understood in many ways,” said Richard B. Lipton, M.D., principal investigator of the NIH-funded Einstein Aging Study and the Edwin S. Lowe Chair in Neurology at Einstein and vice chair of neurology at Einstein and Montefiore. “We are focusing on how the brain ages in the absence of disease, to provide a foundation for identifying the earliest features of Alzheimer’s disease. Early detection is key to implementing effective preventive interventions.”
The research findings are derived from the Einstein Aging Study (EAS), which has tracked cognition in elderly, non-institutionalized Bronx residents since the 1980s. Investigators for each of these studies are available to speak with media.
Oral presentations are:
Poster presentation highlights include:
Several other posters from Einstein–Montefiore researchers will also be presented at AAIC. Topics include white matter hyperintensities, validity of the Memory Binding Test, and gender differences in scores on verbal memory tests.